<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127640">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01765075</url>
  </required_header>
  <id_info>
    <org_study_id>STARLIGHT - 1012</org_study_id>
    <nct_id>NCT01765075</nct_id>
  </id_info>
  <brief_title>Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment</brief_title>
  <acronym>STARLIGHT</acronym>
  <official_title>Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <authority>Czech Republic: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to gather electrophysiological data using a multi-electrode
      mapping catheter during a clinically indicated cardiac ablation procedure for the treatment
      of persistent atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Record 20 sets of electrophysiological data with a multi-electrode mapping catheter.</measure>
    <time_frame>Acute - time of procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Permanent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Patients undergoing cardiac ablation for permanent AF</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Permanent atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or above, or above legal age and willing and capable of giving informed
             consent specific to national law

          -  Scheduled for a clinically indicated cardiac ablation for the treatment of persistent
             atrial fibrillation

          -  Able to meet study requirements for follow-up visit

        Exclusion Criteria:

          -  Permanent leads or presence of prosthetic or severely stenotic tricuspid or mitral
             valves

          -  Active systemic infection or sepsis

          -  Echocardiographically confirmed presence of thrombus

          -  Atrial thrombus, myxoma, inter-atrial baffle patch or occluder device for those
             subjects in whom a transseptal approach is required

          -  Subjects who cannot be anticoagulated or infused with heparinized saline

          -  Heparin induced thrombocytopenia

          -  Hemodynamic instability or shock

          -  Atrial anatomy contradictory to catheter labeling or size indices

          -  EF &lt; 35%

          -  Subjects with an active heart failure decompensation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jas Gill, MA MD FRCP FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guys &amp; St. Thomas' Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Na Homolce</name>
      <address>
        <city>Prague</city>
        <zip>15030</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guys &amp; St. Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 1YR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 3, 2014</lastchanged_date>
  <firstreceived_date>January 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electrophysiological mapping</keyword>
  <keyword>Multi-electrode catheter</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
